MAMohammad Ali Akbarzadeh

Mohammad Ali Akbarzadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Ali Akbarzadeh has a total of 96 co-authors. Here are the top co-authors by number of shared publications:

  • Isa Khaheshi

    Cardiovascular Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    7 shared publications
  • Mohammadreza Naderian

    Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Dept Cardiol, Tehran, Iran

    6 shared publications
  • Morteza Safi

    Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Isa Khaheshi

    Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

    5 shared publications
  • Negar Bahrololoumi Bafruee

    Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Morteza Safi

    Cardiovascular Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

    4 shared publications

Latest Publications

  • Open Access

    Effect of the family-centered empowerment model on health status, functional independence, and post-implantation complications in older adults with cardiac implantable electronic devices: a quasi-experimental study

    by Razieh Ahani Moghaddam, Mahsa Boozari Pour, Fereshteh Javaheri Tehrani, Mohammad Ali Akbarzadeh, Sogand Sarmadi, Akbar Zare-Kaseb, Shabnam Shariatpanahi

  • Open Access

    From Guidelines to Innovation: The Evolving Paradigm of Premature Ventricular Complex Management

    by Tannaz Bagheri, Mohammad Ali Akbarzadeh, Mohammad Javad Namazi

    Context: Premature ventricular complexes (PVCs) are among the most common arrhythmias encountered in clinical practice, affecting up to 75% of individuals during prolonged monitoring. However, their management remains unstructured and inconsistent across centers. Recent studies demonstrate that a high PVC burden independently predicts adverse cardiovascular outcomes, including atrial fibrillation, heart failure, and increased mortality. Nonetheless, current therapeutic approaches rely largely on expert judgment rather than on standardized, evidence-based algorithms. Evidence Acquisition: This narrative review synthesized current evidence on the management of PVCs, including their diagnosis, risk stratification, and treatment options. PubMed and major cardiology journals were searched for publications from 2015 to 2025 using terms including "premature ventricular complex," "PVC management," "catheter ablation," and "ventricular ectopy." Recent systematic reviews, meta-analyses, randomized controlled trials, and major clinical practice guidelines, including the 2017 AHA/ACC/HRS and 2022 ESC guidelines, were prioritized. ClinicalTrials.gov was also searched for ongoing trials relevant to the diagnosis and treatment of PVCs. Results: Recent advances in diagnostic imaging, ablation technology, machine learning, and novel pharmacological agents are increasingly challenging traditional management paradigms. In addition, ongoing clinical trials are evaluating innovative therapeutic approaches and standardized protocols. Conclusions: This narrative review synthesizes current evidence on PVC management, discusses recent findings that are reshaping clinical practice, and presents a vision for the future paradigm of PVC care. In this vision, management becomes truly personalized and guided by objective data. This approach may enable improved diagnostic strategies, refined patient selection criteria, and technological innovations that optimize outcomes for patients with PVCs.

  • Open Access

    Predictors of pacemaker requirement in patients with implantable loop recorder and unexplained syncope: A systematic review and meta‐analysis

    by Moein Zangiabadian, Kiarash Soltani, Yasaman Gholinejad, Reyhane Yahya, Shayan Bastami, Mohammad Ali Akbarzadeh, Mohammad Sharifian Ardestani, Azadeh Aletaha

    Identifying the underlying cause of unexplained syncope is crucial for appropriate management of recurrent syncopal episodes. Implantable loop recorders (ILRs) have emerged as valuable diagnostic tools for monitoring patients with unexplained syncope. However, the predictors of pacemaker requirement in patients with ILR and unexplained syncope remain unclear. In this study, we shed light on these prognostic factors. PubMed/MEDLINE, EMBASE, Web of Science, and Cochrane CENTRAL were systematically searched until May 04, 2023. Studies that evaluated the predictors of pacemaker requirement in patients with implantable loop recorder and unexplained syncope were included. The “Quality In Prognosis Studies” appraisal tool was used for quality assessment. The pooled odds ratio (OR) with 95% confidence intervals (CIs) was calculated. The publication bias was evaluated using Egger's and Begg's tests. Ten studies (n = 4200) were included. Right bundle branch block (OR: 3.264; 95% CI: 1.907–5.588, p < .0001) and bifascicular block (OR: 2.969; 95% CI: 1.859–4.742, p < .0001) were the strongest predictors for pacemaker implantation. Pacemaker requirement was more than two times in patients with atrial fibrillation, sinus bradycardia and first degree AV block. Valvular heart disease, diabetes mellitus, and hypertension were also significantly more in patients with pacemaker implantation. Age (standardized mean difference [SMD]: 0.560; 95% CI: 0.410/0.710, p < .0001) and PR interval (SMD: 0.351; 95% CI: 0.150/0.553, p = .001) were significantly higher in patients with pacemaker requirement. Heart conduction disorders, atrial arrhythmias and underlying medical conditions are main predictors of pacemaker device implantation following loop recorder installation in unexplained syncopal patients.


  • Open Access

    Investigating the Correlation between Obesity Indices and Heart Rate Recovery After Exercise Testing

    by Fahimeh Shakiba, Isa Khaheshi, Mohammad Hasan Namazi, Morteza Safi, Latif Gachkar, Mohammad Ali Akbarzadeh

    Background: Heart rate recovery (HRR) after exercise is a specific measure of the functioning of the autonomic nervous system. A rapid HRR immediately after exercise is associated with a lower risk of cardiovascular disease. Besides, there is a correlation between post-exercise HRR and cardiovascular risk factors. Objectives: This study investigated the correlation between obesity indices after exercise testing and HRR to evaluate the autonomic system and the risk of cardiovascular diseases. Methods: In this cross-sectional study, 108 non-random consecutive patients over 18 years old with indications for exercise testing were selected from those referred to Modarres Hospital in Tehran between 2021 - 2022. The patients were subjected to an exercise test, and the decrease in heart rate was recorded in the first and second minutes after the exercise testing. Then, the correlation between obesity indices and risk factors for cardiovascular diseases and the HHR was evaluated. Results: Based on our results, none of the obesity indices such as weight, height, BMI, neck circumference, waist circumference, hip circumference, WHR, ABSI, ABI, or BAI showed a significant correlation with the reduction of the heart rate one and two minutes after the exercise test. However, the heart rate reduction one minute after the exercise test was significantly lower in patients with a family history of heart disease. Also, the heart rate reduction two minutes after the exercise test was significantly lower in diabetic patients, hyperlipidemic patients, and patients with insufficient sleep. Conclusions: Although there was no significant correlation between obesity indices and heart rate reduction after exercise tests due to the harmful effects of obesity and overweight on cardiac function and its increasing prevalence, clinical trial studies will be beneficial in clarifying the effects of obesity indices on cardiac efficiency.

  • Open Access

    Associations between short‐term exposure to fine particulate matter and acute myocardial infarction: A case‐crossover study

    by Shiva Tabaghi, Mehdi Sheibani, Isa Khaheshi, Reza Miri, Mohammad Haji Aghajani, Morteza Safi, Vahid Eslami, Mehdi Pishgahi, Saeed Alipour Parsa, Mohammad Hassan Namazi, et al.

    Background: Previous studies evaluated the impact of particle matters (PM) on the risk of acute myocardial infarction (AMI) based on local registries.Hypothesis: This study aimed to evaluate possible short term effect of air pollutants on occurrence of AMI based on a specific case report sheet that was designed for this purpose.Methods: AMI was documented among 982 patients who referred to the emergency departments in Tehran, Iran, between July 2017 to March 2019. For each patient, case period was defined as 24 hour period preceding the time of emergency admission and referent periods were defined as the corresponding time in 1, 2, and 3 weeks before the admission. The associations of particulate matter with an aerodynamic diameter ≤2.5 μm (PM2.5) and particulate matter with an aerodynamic diameter ≤10 μm (PM10) with AMI were analyzed using conditional logistic regression in a case‐crossover design.Result: Increase in PM2.5 and PM10 was significantly associated with the occurrence of AMI with and without adjustment for the temperature and humidity. In the adjusted model each 10 μg/m3 increase of PM10 and PM2.5 in case periods was significantly associated with increase myocardial infarction events (95% CI = 1.041−1.099, OR = 1.069 and 95% CI = 1.073−1.196, and OR = 1.133, respectively). Subgroup analysis showed that increase in PM10 did not increase AMI events in diabetic subgroup, but in all other subgroups PM10 and PM2.5 concentration showed positive associations with increased AMI events.Conclusion: Acute exposure to ambient air pollution was associated with increased risk of AMI irrespective of temperature and humidity.


  • Open Access

    Clinical Predictors of Successful Anti-tachycardia Pacing for Ventricular Arrhythmia Termination

    by Shiva Tabaghi, Elham Mahmoudi, Mohammad Hasan Namazi, Isa Khaheshi, Mohammad Ali Akbarzadeh

    Background: Anti-tachycardia pacing (ATP) is a fast and safe method for terminating ventricular tachycardia (VT). Implantable cardioverter defibrillator (ICD) shocks are unpleasant, stressful experiences that have been associated with higher mortality rates than ATP. Determining the factors enhancing the efficacy of ATP therapies can minimize the appropriate ICD shocks. Objectives: In this study, we investigated the factors anticipating the success rate of ATP. Methods: This descriptive cross-sectional study was carried out among 60 patients referring to our center for regular ICD device analysis. These patients had at least one episode of appropriate ATP therapy in their analysis. The VT morphologic characteristics were obtained from stored far-field intracardiac electrogram (EGM). The VT episodes and native QRS were classified into non-Q or Q categories based on their EGM morphologies. Results: ATP was successful in 38 (63.3%) cases. Age, sex, history of ischemic heart disease and diabetes, type of device and cardiomyopathy (ischemic or dilated), antiarrhythmic drugs, left ventricular ejection fraction, and EGM characteristics did not predict ATP success. Conclusions: It seems that neither the demographic factors nor the morphologic characteristics of VT EGMs can predict the efficacy of ATP therapy.

  • Open Access

    Methadone-Induced QT Interval Prolongation and Torsades de Pointes

    by Shiva Tabaghi, Mohammad Ali Akbarzadeh

    : The most common cause of acquired long QT syndrome in patients without physiological and structural cardiovascular disease is the use of medications. Chronic high-dose methadone usage can cause prolongation of QT interval that may provoke the life-threatening arrhythmia Torsades de Pointes. In this study, we present a 41-year-old man with chronic high-dose methadone usage who developed Torsades de Pointes triggered by short-coupled premature ventricular contraction.

  • Open Access

    Acute type A aortic dissection in a patient with COVID-19

    by Shiva Tabaghi, Mohammad Ali Akbarzadeh

    The novel coronavirus spread all over the world in 2019 and became a serious international health concern of this century. Coronavirus disease 2019 (COVID-19) had a wide range of clinical manifestations; it can cause mild-to-severe multiorgan diseases, mostly affecting the respiratory system, but cardiovascular symptoms and complications are also frequently presented in COVID-19 patients. Herein, we report a type A aortic dissection in a confirmed case of COVID-19.


  • Open Access

    Cardiogoniometry can predict positive response to cardiac resynchronization therapy – A proof of concept study

    by Azin Alizadehasl, Mohammad Ali Akbarzadeh, Anita Sadeghpour, Majid Haghjoo, Behshid Ghadrdoost, Mahbubeh Zeighami, Arezoo Haghighat Talab